NTCOC
JAZZ icon

Northern Trust Company of Connecticut’s Jazz Pharmaceuticals JAZZ Stock Holding History

Northern Trust Company of Connecticut’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$292K Sell
2,308
-28,700
-93% -$2.97M ﹤0.01% 1692
2013
Q3 		$2.85M Sell
31,008
-28,350
-48% -$2.29M 0.02% 910
2013
Q2 		$4.08M Buy
+59,358
New +$3.63M 0.03% 737

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
WBC
Westpac Banking Corp Sydney, Australia $1.62B AUM 39.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Company of Connecticut's JAZZ Position: Q4 2013 in Review

Northern Trust Company of Connecticut reduced its Jazz Pharmaceuticals (JAZZ) stake by 93% in Q4 2013, selling an estimated $2.97M and leaving 2,308 shares worth $292K. The position accounts for ﹤0.01% of the portfolio, ranked #1692.

Northern Trust Company of Connecticut first reported a position in JAZZ in Q2 2013 and has held it in 3 quarters since. The position peaked at $4.08M in Q2 2013. 280 funds tracked by Wall St. Rank hold JAZZ as of Q4 2013.

  • Northern Trust Company of Connecticut held 2,308 shares of Jazz Pharmaceuticals worth $292K as of Q4 2013.
  • Northern Trust Company of Connecticut sold 28,700 Jazz Pharmaceuticals shares in Q4 2013, an estimated $2.97M.
  • Jazz Pharmaceuticals made up ﹤0.01% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #1692 holding.
  • Northern Trust Company of Connecticut first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • Northern Trust Company of Connecticut's Jazz Pharmaceuticals position peaked at $4.08M in Q2 2013.
  • 280 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.